Induction of p53 in keratinocyte cultures treated with Behçet's patient sera.

BACKGROUND Behçet's disease is a rare, multisystem vasculitis disease characterized by recurrent orogenital ulcerations with its etiology remained unclear. The transcription factor p53 has been reported to be upregulated in some autoimmune diseases, such as lupus erythematosus, dermatomyositis, and psoriasis. However, little is known about its alteration in Behçet's disease. METHODS Keratinocyte cultures of both skin and oral origins were treated sera of 18 Behcet patients for 24 hours and analyzed by indirect immunofluorescence for p53 expression. The specificity of p53 expression was confirmed by siRNA mediated p53 knockdown and the serum IgG removal studies. The expression of p53 levels was quantitatively analyzed with ImageJ. RESULTS It was shown that the expression of p53 is increased in skin and oral keratinocyte cell lines, in both the nucleus and cytoplasm of cells treated with patient sera compared to controls. Either p53 knockdown or IgG removal results in a reduction of p53 levels relative to cells treated with patient sera without p53 knockdown or IgG depletion. CONCLUSIONS This in vitro study provides the first evidence that Behçet's disease sera can induce the p53 expression in keratinocytes that may have implications in Behcet pathogenesis.

[1]  Angray S. Kang,et al.  The desmosomal cadherin desmoglein-3 acts as a keratinocyte anti-stress protein via suppression of p53 , 2019, Cell Death & Disease.

[2]  M. Ralli,et al.  Behçet's disease: New insights into pathophysiology, clinical features and treatment options. , 2018, Autoimmunity reviews.

[3]  C. Lunardi,et al.  MicroRNA Expression Profiling in Behçet's Disease , 2018, Journal of immunology research.

[4]  E. Tinazzi,et al.  Gene Expression Profiling in Behcet's Disease Indicates an Autoimmune Component in the Pathogenesis of the Disease and Opens New Avenues for Targeted Therapy , 2018, Journal of immunology research.

[5]  D. Klatzmann,et al.  Behçet’s disease physiopathology: a contemporary review , 2016, Autoimmunity Highlights.

[6]  Sheng-Hsiang Lin,et al.  Risk of Overall and Site-specific Cancers in Behçet Disease: A Nationwide Population-based Study in Taiwan , 2015, The Journal of Rheumatology.

[7]  Kamran Moradi,et al.  Genital aphthosis in Behçet’s disease: Is it associated with less eye involvement? , 2014, Rheumatology International.

[8]  Eun-So Lee,et al.  Morbidity of Solid Cancer in Behçet's Disease: Analysis of 11 Cases in a Series of 506 Patients , 2013, Yonsei medical journal.

[9]  D. Saadoun,et al.  Behçet's disease , 2012, Orphanet Journal of Rare Diseases.

[10]  G. Kokolakis,et al.  Infliximab restores the balance between pro‐ and anti‐apoptotic proteins in regressing psoriatic lesions , 2012, The British journal of dermatology.

[11]  G. Vena,et al.  Influence of infliximab on keratinocyte apoptosis in psoriasis patients , 2011, Immunopharmacology and immunotoxicology.

[12]  S. Lowe,et al.  Tumor suppressive functions of p53. , 2009, Cold Spring Harbor perspectives in biology.

[13]  A. Levine,et al.  The first 30 years of p53: growing ever more complex , 2009, Nature Reviews Cancer.

[14]  D. Weinreb,et al.  Expression of p53 and apoptosis in discoid lupus erythematosus. , 2005, Croatian medical journal.

[15]  T. Horiuchi,et al.  Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. , 2005, Gastroenterology.

[16]  W. Hahn,et al.  Human Keratinocytes That Express hTERT and Also Bypass a p16INK4a-Enforced Mechanism That Limits Life Span Become Immortal yet Retain Normal Growth and Differentiation Characteristics , 2000, Molecular and Cellular Biology.

[17]  J. Gómez-Reino,et al.  Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis , 1999, The Journal of pathology.

[18]  O. S. Kwon,et al.  Apoptosis in the pathogenesis of cutaneous lupus erythematosus. , 1998, The American Journal of dermatopathology.

[19]  G. Firestein,et al.  Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. , 1996, The American journal of pathology.

[20]  R. Moots,et al.  Behcet's disease , 2017, Clinical medicine.

[21]  T. Batinac,et al.  Expression of Bcl-2 family proteins in psoriasis. , 2007, Croatian medical journal.

[22]  T. Batinac,et al.  Expression of p53 and apoptosis in discoid lupus erythematosus. , 2005, Croatian medical journal.